Favorites Sign in
  1. Home
  2. Companies
  3. Stock Aptose Biosciences
Aptose Biosciences logo

Aptose Biosciences APTO

report update icon

Quarterly report 2026-Q1
added 05-13-2026

Country

 canadaCanada

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ CAPITAL

Shares

 2.45 M

Market Cap[1]

 $ 1.2 M

EBITDA (LTM)

 $ 22 K

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -10.41

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Viridian Therapeutics Viridian Therapeutics
VRDN
 		$ 30.86 2.22 % $ 3.14 B Nasdaq Capital Market usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
 		- - $ 2.81 B Nasdaq Global Select Market,SPB usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		- - $ 1.94 B Nasdaq Capital Market canadaCanada
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
 		- - $ 532 M Nasdaq Global Select Market britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		- - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
 		- 0.52 % $ 821 M Nasdaq Global Select Market danmarkDanmark
Zogenix, Inc. Zogenix, Inc.
ZGNX
 		- -4.97 % $ 664 M Nasdaq Global Market,SPB usaUSA
Yunhong International Yunhong International
ZGYH
 		- 0.10 % $ 92.2 M Nasdaq Capital Market chinaChina
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
 		- -7.58 % $ 264 M Nasdaq Global Select Market usaUSA
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
 		$ 41.4 2.35 % $ 3.28 B Nasdaq Global Select Market canadaCanada
Leap Therapeutics Leap Therapeutics
LPTX
 		- 368.57 % $ 41.9 M Nasdaq Global Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 31.45 2.08 % $ 1.62 B NYSE canadaCanada
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
 		$ 3.15 -35.42 % $ 2.11 M Nasdaq Capital Market usaUSA
ADMA Biologics ADMA Biologics
ADMA
 		$ 12.67 -0.98 % $ 3.02 B Nasdaq Global Market usaUSA
Cortexyme Cortexyme
CRTX
 		- -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Burford Capital Limited Burford Capital Limited
BUR
 		$ 3.66 -1.35 % $ 802 M NYSE britainBritain
Daré Bioscience Daré Bioscience
DARE
 		$ 0.69 1.75 % $ 7.71 M Nasdaq Capital Market usaUSA
Fate Therapeutics Fate Therapeutics
FATE
 		$ 1.78 -8.51 % $ 211 M Nasdaq Global Market,SPB usaUSA
Greenwich LifeSciences Greenwich LifeSciences
GLSI
 		$ 16.05 -2.85 % $ 217 M Nasdaq Capital Market usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
 		$ 103.0 0.08 % $ 12.3 B Nasdaq Global Select Market,SPB usaUSA
Hutchison China MediTech Limited Hutchison China MediTech Limited
HCM
 		$ 15.34 0.1 % $ 13.2 B Nasdaq Global Select Market chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
 		- - $ 5.72 M Nasdaq Global Select Market chinaChina
iBio iBio
IBIO
 		$ 0.78 -1.89 % $ 81.2 M NYSE American usaUSA
Kodiak Sciences Kodiak Sciences
KOD
 		$ 108.01 0.85 % $ 5.75 B Nasdaq Global Market,SPB usaUSA
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
 		$ 0.02 -54.5 % $ 219 Nasdaq Global Select Market usaUSA
FSD Pharma FSD Pharma
HUGE
 		- 5743.5 % $ 69.7 M Nasdaq Capital Market canadaCanada
BioAtla BioAtla
BCAB
 		$ 1.74 0.64 % $ 102 M Nasdaq Global Select Market usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
 		- - $ 3.85 B Nasdaq Capital Market usaUSA
UroGen Pharma Ltd. UroGen Pharma Ltd.
URGN
 		$ 25.32 -3.78 % $ 1.22 B Nasdaq Global Select Market israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
 		$ 13.91 1.9 % $ 1.24 B Nasdaq Capital Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
 		- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Acasti Pharma Acasti Pharma
ACST
 		- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
ADiTx Therapeutics ADiTx Therapeutics
ADTX
 		- - $ 374 Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
 		- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
AlloVir AlloVir
ALVR
 		- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
 		- - $ 5.18 B Nasdaq Global Select Market,SPB usaUSA
Athira Pharma Athira Pharma
ATHA
 		- - $ 269 M Nasdaq Global Select Market usaUSA
AVROBIO AVROBIO
AVRO
 		- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
 		- - $ 96.9 B Nasdaq Global Select Market britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
 		- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
 		$ 0.39 9.06 % $ 28.6 K Nasdaq Global Market usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
 		- - $ 100 K Nasdaq Capital Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
 		- -0.88 % $ 598 M Nasdaq Capital Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
 		- -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.